Arizona State Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Buy
23,873
+656
+3% +$31.9K 0.01% 1026
2025
Q1
$790K Sell
23,217
-251
-1% -$8.54K 0.01% 1181
2024
Q4
$924K Buy
23,468
+239
+1% +$9.41K 0.01% 1144
2024
Q3
$1.09M Buy
23,229
+650
+3% +$30.5K 0.01% 1055
2024
Q2
$1.22M Buy
22,579
+1,841
+9% +$99.4K 0.01% 942
2024
Q1
$1.41M Sell
20,738
-351
-2% -$23.9K 0.01% 874
2023
Q4
$1.32M Sell
21,089
-262
-1% -$16.4K 0.01% 889
2023
Q3
$969K Buy
21,351
+365
+2% +$16.6K 0.01% 1011
2023
Q2
$1.18M Sell
20,986
-565
-3% -$31.7K 0.01% 928
2023
Q1
$975K Buy
21,551
+640
+3% +$28.9K 0.01% 1023
2022
Q4
$850K Buy
20,911
+915
+5% +$37.2K 0.01% 1067
2022
Q3
$1.31M Buy
19,996
+120
+0.6% +$7.84K 0.01% 790
2022
Q2
$1.21M Buy
19,876
+3,327
+20% +$202K 0.01% 861
2022
Q1
$1.04M Buy
16,549
+142
+0.9% +$8.92K 0.01% 1049
2021
Q4
$1.24M Sell
16,407
-104
-0.6% -$7.88K 0.01% 975
2021
Q3
$1.85M Buy
16,511
+108
+0.7% +$12.1K 0.02% 752
2021
Q2
$2.66M Sell
16,403
-810
-5% -$131K 0.02% 615
2021
Q1
$2.1M Buy
17,213
+1,951
+13% +$238K 0.02% 708
2020
Q4
$2.34M Sell
15,262
-214
-1% -$32.8K 0.02% 620
2020
Q3
$1.29M Buy
15,476
+6,549
+73% +$548K 0.01% 791
2020
Q2
$656K Buy
8,927
+1,875
+27% +$138K 0.01% 977
2020
Q1
$299K Buy
+7,052
New +$299K 0.01% 1288